Your browser doesn't support javascript.
loading
Structure-guided stabilization of pathogen-derived peptide-HLA-E complexes using non-natural amino acids conserves native TCR recognition.
Barber, Claire; De Souza, Victoria Arena; Paterson, Rachel L; Martin-Urdiroz, Magdalena; Mulakkal, Nitha Charles; Srikannathasan, Velupillai; Connolly, Mary; Phillips, Gwilym; Foong-Leong, Tein; Pengelly, Robert; Karuppiah, Vijaykumar; Grant, Tressan; Dembek, Marcin; Verma, Anil; Gibbs-Howe, Dawn; Blicher, Thomas H; Knox, Andrew; Robinson, Ross A; Cole, David K; Leonard, Sarah.
Afiliación
  • Barber C; Immunocore Ltd, Abingdon, Oxfordshire, UK.
  • De Souza VA; Immunocore Ltd, Abingdon, Oxfordshire, UK.
  • Paterson RL; Immunocore Ltd, Abingdon, Oxfordshire, UK.
  • Martin-Urdiroz M; Immunocore Ltd, Abingdon, Oxfordshire, UK.
  • Mulakkal NC; Immunocore Ltd, Abingdon, Oxfordshire, UK.
  • Srikannathasan V; Immunocore Ltd, Abingdon, Oxfordshire, UK.
  • Connolly M; Immunocore Ltd, Abingdon, Oxfordshire, UK.
  • Phillips G; Immunocore Ltd, Abingdon, Oxfordshire, UK.
  • Foong-Leong T; Immunocore Ltd, Abingdon, Oxfordshire, UK.
  • Pengelly R; Immunocore Ltd, Abingdon, Oxfordshire, UK.
  • Karuppiah V; Immunocore Ltd, Abingdon, Oxfordshire, UK.
  • Grant T; Immunocore Ltd, Abingdon, Oxfordshire, UK.
  • Dembek M; Immunocore Ltd, Abingdon, Oxfordshire, UK.
  • Verma A; Immunocore Ltd, Abingdon, Oxfordshire, UK.
  • Gibbs-Howe D; Immunocore Ltd, Abingdon, Oxfordshire, UK.
  • Blicher TH; Immunocore Ltd, Abingdon, Oxfordshire, UK.
  • Knox A; Immunocore Ltd, Abingdon, Oxfordshire, UK.
  • Robinson RA; Immunocore Ltd, Abingdon, Oxfordshire, UK.
  • Cole DK; Immunocore Ltd, Abingdon, Oxfordshire, UK.
  • Leonard S; Immunocore Ltd, Abingdon, Oxfordshire, UK.
Eur J Immunol ; 52(4): 618-632, 2022 04.
Article en En | MEDLINE | ID: mdl-35108401
ABSTRACT
The nonpolymorphic class Ib molecule, HLA-E, primarily presents peptides from HLA class Ia leader peptides, providing an inhibitory signal to NK cells via CD94/NKG2 interactions. Although peptides of pathogenic origin can also be presented by HLA-E to T cells, the molecular basis underpinning their role in antigen surveillance is largely unknown. Here, we solved a co-complex crystal structure of a TCR with an HLA-E presented peptide (pHLA-E) from bacterial (Mycobacterium tuberculosis) origin, and the first TCR-pHLA-E complex with a noncanonically presented peptide from viral (HIV) origin. The structures provided a molecular foundation to develop a novel method to introduce cysteine traps using non-natural amino acid chemistry that stabilized pHLA-E complexes while maintaining native interface contacts between the TCRs and different pHLA-E complexes. These pHLA-E monomers could be used to isolate pHLA-E-specific T cells, with obvious utility for studying pHLA-E restricted T cells, and for the identification of putative therapeutic TCRs.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aminoácidos / Antígenos HLA Idioma: En Revista: Eur J Immunol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aminoácidos / Antígenos HLA Idioma: En Revista: Eur J Immunol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido